Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Journal of Clinical Pharmacology
|
December 17, 2025
Elranatamab Exposure-Safety Analysis in Relapsed or Refractory Multiple Myeloma
Pooneh Soltantabar, Jennifer Hibma, Diane Wang, et al.
Targeted Oncology
|
August 20, 2025
Elranatamab Fixed Dosing: A Safe, Effective, and Convenient Dosing Approach
Mohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
November 16, 2023
Optimizing Ophthalmology Patient Education via ChatBot-Generated Materials: Readability Analysis of AI-Generated Patient Education Materials and The American Society of Ophthalmic Plastic and Reconstructive Surgery Patient Brochures
Kevin Eid, Alen Eid, Diane Wang, et al.
Oncology and Therapy
|
March 2, 2026
Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing Approach
Mohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
June 17, 2020
Oscillatory potentials in patients with birdshot chorioretinopathy
Diane Wang, Archana Nair, Naomi Goldberg, et al.
Respiratory Physiology & Neurobiology
|
March 2, 2010
Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice
Ann-Sophie Alm, Ka Li, Hong Chen, et al.
Respiratory Medicine
|
July 20, 2010
Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease
Chun-zhen Zhao, Xiao-cong Fang, Diane Wang, et al.
Journal of Cellular and Molecular Medicine
|
June 17, 2010
Role of aquaporin 5 in antigen-induced airway inflammation and mucous hyperproduction in mice
Yao Shen, Yaoli Wang, Zhihong Chen, et al.
Journal of Translational Medicine
|
April 18, 2015
Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?
Jian Wang, Li Feng, Zhitu Zhu, et al.
NPJ Systems Biology and Applications
|
September 1, 2025
Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myeloma
Kamrine E Poels, Mohamed Elmeliegy, Jennifer Hibma, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Journal of Clinical Pharmacology
|
December 17, 2025
Elranatamab Exposure-Safety Analysis in Relapsed or Refractory Multiple Myeloma
Pooneh Soltantabar, Jennifer Hibma, Diane Wang, et al.
Targeted Oncology
|
August 20, 2025
Elranatamab Fixed Dosing: A Safe, Effective, and Convenient Dosing Approach
Mohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
November 16, 2023
Optimizing Ophthalmology Patient Education via ChatBot-Generated Materials: Readability Analysis of AI-Generated Patient Education Materials and The American Society of Ophthalmic Plastic and Reconstructive Surgery Patient Brochures
Kevin Eid, Alen Eid, Diane Wang, et al.
Oncology and Therapy
|
March 2, 2026
Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing Approach
Mohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
June 17, 2020
Oscillatory potentials in patients with birdshot chorioretinopathy
Diane Wang, Archana Nair, Naomi Goldberg, et al.
Respiratory Physiology & Neurobiology
|
March 2, 2010
Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice
Ann-Sophie Alm, Ka Li, Hong Chen, et al.
Respiratory Medicine
|
July 20, 2010
Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease
Chun-zhen Zhao, Xiao-cong Fang, Diane Wang, et al.
Journal of Cellular and Molecular Medicine
|
June 17, 2010
Role of aquaporin 5 in antigen-induced airway inflammation and mucous hyperproduction in mice
Yao Shen, Yaoli Wang, Zhihong Chen, et al.
Journal of Translational Medicine
|
April 18, 2015
Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?
Jian Wang, Li Feng, Zhitu Zhu, et al.
NPJ Systems Biology and Applications
|
September 1, 2025
Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myeloma
Kamrine E Poels, Mohamed Elmeliegy, Jennifer Hibma, et al.
Page
of 7